Company news

Zentalis Pharmaceuticals, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Zentalis Pharmaceuticals Announces the Appointment of Dr. Enoch Kariuki to its Board of Directors

February 9, 2021

Zentalis Pharmaceuticals Announces the Initiation of Multiple Early-Stage Clinical Trials

January 5, 2021

Zentalis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Update

November 8, 2020

Zentalis Pharmaceuticals Appoints Alexis Pinto as Chief Legal Officer

August 31, 2020

Zentalis Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Update

August 12, 2020

Zentalis Pharmaceuticals Announces Pricing of Upsized Offering of Common Stock

July 28, 2020

Zentalis Pharmaceuticals Enters into Clinical Collaboration with Eli Lilly and Company to Evaluate its Oral SERD ZN-c5 in Combination with Abemaciclib, a CDK4 and 6 Inhibitor

July 26, 2020

Zentalis Pharmaceuticals Announces the Appointment of Dr. Kimberly Blackwell to its Board of Directors

June 30, 2020

Zentalis Pharmaceuticals and Tavros Therapeutics Announce Strategic Platform Collaboration to Discover Next Generation Targeted Small Molecule Therapies

May 27, 2020

Zentalis Pharmaceuticals Announces $20 Million Series A Financing to Establish a Chinese Joint Venture, Zentera Therapeutics

May 19, 2020

Zentalis Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Update

May 14, 2020

Zentalis Pharmaceuticals Announces FDA Clearance of IND Application for ZN-d5 for the Treatment of Hematologic Malignancies

April 29, 2020

Zentalis Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

April 6, 2020

Zentalis Pharmaceuticals Announces Pricing of Initial Public Offering

April 1, 2020

← Newer news releases

Decks

The 5 newest of 23 decks. Every deck is listed under its year.